As of 28/09/2023
Index Information
Index Details
The index tracks targeted exposure to the rapidly expanding legal medical cannabis industry that is set for further growth as more countries legalise cannabis for medical use.
This consists of publicly listed companies conducting legal business activities across nine thematic sub-sectors in the medical cannabis, hemp and CBD industries.
Methodology
- Screening Process: Step 1 Universe: Publicly traded on a stock exchange; Step 2 Exchanges: Must be listed on an approved exchange: NASDAQ, NYSE, TSX or TSX-V; Step 3 Tradability: >$30M market cap, >$200k minimum liquidity; Step 4 Revenue trace: Excludes recreational cannabis securities
-
Weighting: Constituent weights are capped at 15% at rebalances to avoid excessive concentration in the largest companies
-
Calculation: Calculated every 15 seconds; Quarterly rebalance; Full physical index replication
To view the Methodology
click here.